Literature DB >> 9037955

Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.

A T Lörincz1.   

Abstract

High- and intermediate-risk types of human papillomavirus (HPV) in concert with cofactors are responsible for over 90% of cervical cancers world-wide. While the Pap smear is a valuable cancer prevention tool, its subjective nature leaves it error prone. As a result, HPV DNA testing appears to be a needed adjunct to the Pap smear. Hybrid Capture is a simple DNA test with high specificity and sensitivity which appears useful for clinical management of equivocal Pap tests and shows promise for mass screening.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9037955     DOI： 10.1111/j.1447-0756.1996.tb01081.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN： 1341-8076            Impact factor:   1.730


  21 in total

1.  HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAP.

Authors:  Brian Lowe; Lori Kobayashi; Attila Lorincz; Rick Mallonee; Dominic O'Neil; Ha Thai; Irina Nazarenko
Journal:  J Mol Diagn       Date:  2010-09-16       Impact factor: 5.568

2.  Detecting every genital papilloma virus infection: what does it mean?

Authors:  C P Crum
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

3.  Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.

Authors:  C E Depuydt; I H Benoy; J F A Beert; A M Criel; J J Bogers; M Arbyn
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

4.  Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia.

Authors:  J Kónya; G Veress; A Juhász; K Szarka; T Sápy; Z Hernádi; L Gergely
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18.

Authors:  H A Cubie; A L Seagar; E McGoogan; J Whitehead; A Brass; M J Arends; M W Whitley
Journal:  Mol Pathol       Date:  2001-02

6.  p16 expression in squamous lesions of the female genital tract.

Authors:  Mary M Finegan; Aaron C Han; Mitchell I Edelson; Norman G Rosenblum
Journal:  J Mol Histol       Date:  2004-02       Impact factor: 2.611

7.  Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

Authors:  Mario Poljak; Bostjan J Kocjan; Anja Kovanda; Maja M Lunar; Snjezana Zidovec Lepej; Ana Planinic; Katja Seme; Adriana Vince
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

8.  Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications.

Authors:  Morie Nishiwaki; Tomohiro Yamamoto; Somako Tone; Taichi Murai; Tatsuya Ohkawara; Takakuni Matsunami; Motoiki Koizumi; Yoshitake Takagi; Jun Yamaguchi; Nobuo Kondo; Jun Nishihira; Takeharu Horikawa; Takashi Yoshiki
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

9.  Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.

Authors:  C L Peyton; M Schiffman; A T Lörincz; W C Hunt; I Mielzynska; C Bratti; S Eaton; A Hildesheim; L A Morera; A C Rodriguez; R Herrero; M E Sherman; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

10.  Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis.

Authors:  Yiqun Liao; Yulin Zhou; Qiwei Guo; Xiaoting Xie; Ena Luo; Jian Li; Qingge Li
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.